Head-to-head · Cost-Efficiency Index
Nova MD vs StackMD
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Nova MD
Shoppers who want an explicit tirzepatide dose-titration schedule alongside tiered pricing.
Visit Nova MDStackMD
Shoppers price-scanning for the lowest advertised entry point, who should confirm true dose-adjusted cost before signing up.
Visit StackMDThe verdict
Nova MD and StackMD tie on the Cost-Efficiency Index at 60/100, so neither wins outright on the numbers. For most shoppers we'd start with Nova MD (ranked #254, a hair above #257) — Shoppers who want an explicit tirzepatide dose-titration schedule alongside tiered pricing. But StackMD is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Nova MD.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Nova MD | StackMD |
|---|---|---|
| Cost-Efficiency Index | 60/100 | 60/100 |
| Semaglutide / mo | $175/mo (compounded) | Not disclosed |
| Tirzepatide / mo | $199/mo (compounded) | Not disclosed |
| Semaglutide / yr (modeled) | $2,100 | — |
| Tirzepatide / yr (modeled) | $2,388 | — |
| Coverage | Coverage not published | All 50 states |
| Oral / sublingual | No | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #254 | #257 |
Nova MD
60/100Where the value is
- Full 1/3/6/12-month tirzepatide pricing ladder disclosed, down to $149/mo on the annual plan
- Explicit monthly dose-titration schedule published for tirzepatide (2.5mg to 15mg over 6 months) — more clinical detail than most competitors in this set show
- LegitScript verification badge present with a working link to legitscript.com
The tradeoffs
- No compounding pharmacy is named — only 'Licensed U.S. Pharmacy'
- No state-coverage list is published anywhere on the public site (checked homepage, medical-disclaimers, and refund-policy pages)
StackMD
60/100Where the value is
- Low advertised entry price ($99/mo) for both semaglutide and tirzepatide
- Clear FDA-compounding disclaimer shown up front
- Distinct national telehealth brand (separate from the similarly-named Long Island clinic)
The tradeoffs
- Identical $99 headline for both drugs strongly suggests a lowest-dose teaser, not full treatment pricing
- No dose tiers, medical director, pharmacy name, states list, or LegitScript status could be confirmed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.